# RADIQAL Study (Radiation Dose and Image Quality Trial)

> **NCT06944509** · NA · RECRUITING · sponsor: **Philips Clinical & Medical Affairs Global** · enrollment: 824 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** treatment with the Azurion system with Xres5
- **OTHER:** Azurion with Clairy IQ

## Key facts

- **NCT ID:** NCT06944509
- **Lead sponsor:** Philips Clinical & Medical Affairs Global
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 824 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06944509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06944509, "RADIQAL Study (Radiation Dose and Image Quality Trial)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06944509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*